Louisiana 2014 Regular Session

Louisiana Senate Bill SCR39

Introduced
3/24/14  
Introduced
3/24/14  
Refer
3/25/14  
Refer
3/25/14  
Report Pass
4/2/14  
Report Pass
4/2/14  
Passed
4/7/14  
Passed
4/7/14  
Engrossed
4/8/14  
Engrossed
4/8/14  
Refer
4/9/14  
Refer
4/9/14  
Report Pass
5/21/14  

Caption

Requests the Department of Health and Hospitals to study the most effective means to ensure the proper utilization of Attention Deficit Hyperactivity Disorder medications in Louisiana and to report its findings to the legislature.

Impact

The resolution signifies a proactive measure by the Louisiana Legislature to address the growing concern of ADHD medication usage and its implications for public health. By urging a study, the bill aims to ensure that ADHD medications are being used appropriately and that any potential issues associated with their misuse or overprescription are thoroughly examined. The outcome of this study could lead to new guidelines or recommendations from health authorities regarding ADHD treatments and their management in the state.

Summary

Senate Concurrent Resolution No. 39 requests the Department of Health and Hospitals of Louisiana to conduct a study on the proper usage of Attention Deficit Hyperactivity Disorder (ADHD) medications within the state. The bill highlights the alarming increase in ADHD medication prescriptions, particularly among young adults and girls, and positions this issue as a pressing public health priority. The rise in the use of these medications poses potential risks, including addiction and adverse reactions, thereby necessitating an evaluation of their proper utilization across Louisiana.

Sentiment

The general sentiment surrounding SCR39 appears to be supportive, as it reflects a recognition of the increasing prevalence of ADHD prescriptions and the need for oversight to safeguard public health. Legislators and stakeholders seem to agree on the necessity of addressing the potential for misuse and the importance of ensuring that ADHD medications are used effectively and safely in Louisiana.

Contention

While the resolution itself does not appear to face significant opposition, the underlying concerns about ADHD medication misuse and the implications of their increase in usage highlight potential contention. Discussions may arise regarding the appropriateness of existing ADHD treatments and the balance between accessibility and safety. The resolution emphasizes collaboration with stakeholders, indicating a willingness to address these complexities in the larger context of mental health care and medication management.

Companion Bills

No companion bills found.

Previously Filed As

LA SCR137

Requests DHH to study the most effective means to ensure the proper utilization of inhalers by school nurses and report to the Senate and House Committees on Health and Welfare.

LA HR0157

A resolution to declare October 22-28, 2023, as Attention Deficit Hyperactivity Disorder Awareness Week in Michigan.

LA HCR15

Requests a study of the most effective means by which to reduce Louisiana's rate of suicide

LA SB00150

An Act Concerning Drugs Prescribed To Treat Attention-deficit/hyperactivity Disorder.

LA S3388

Allows pharmacists to transfer Schedule II attention-deficit/hyperactivity disorder prescriptions.

LA A4391

Allows pharmacists to transfer Schedule II attention-deficit/hyperactivity disorder prescriptions.

LA SCR132

the Department of Health and Hospitals to conduct a study on access to psychiatric medications and the costs for nonaccess to such medications.

LA HR164

Requests DHH to study the most effective means by which to ensure open access to HIV/AIDS and hepatitis C medications by persons enrolled in Medicaid managed care

LA HR222

Requests the Louisiana Department of Health to evaluate factors affecting children who are diagnosed with autism spectrum disorder in this state and their families

LA SCR2

Requests the Department of Health and Hospitals to submit a report to the Legislature of Louisiana that addresses how the department and its contractors combat Medicaid fraud and abuse.

Similar Bills

No similar bills found.